- VANUDIS - Biotech Company
- SkyAngle Building
- Max-Jarecki-Str. 21
- 69115 Heidelberg
- office@vanudis.net
- +49 6221 3919 0
The Goal
Our ambition is to design, engineer, develop and deliver cutting edge medicines for patients
VANUDIS is a biotechnology company founded to set new standards in the development of novel proprietary immunotherapeutics. Based on longstanding experience of its key members VANUDIS can cover the entire spectrum from early preclinical discovery to the translation of innovative antibody-based drug candidates and cellular therapeutics into successful clinical applications.
Key technologies include methods for generating biophysically stable humanized antibody fragments and human antibody phage display libraries created from B cell repertoires of immunized cancer patient donors and blood cord, respectively. Antibodies with therapeutic potential are selected from these libraries and initially processed into robust antibody fragment modules.
In a subsequent step, these modules are developed into therapeutic drug candidates. The development of therapeutic drug classes is focused on CAR cell therapeutics, immuno-riboculeases („ImmunoRNAses“), and antibody therapeutics derived from the innate immune system.